About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Swallow Solutions Swallow Solutions StrideBio, LLC StrideBio, LLC Cybrexa Therapeutics Cybrexa Therapeutics Acessa Acessa Diasome Diasome Actinobac Biomed, Inc. Actinobac Biomed, Inc. Fedora Pharmaceuticals Fedora Pharmaceuticals Neurohacker Neurohacker Meissa Vaccines Meissa Vaccines GEN1 Biotechnology GEN1 Biotechnology

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 10

Portfolio

Portfolio tracker

Acquisitions 4

Apps 1
Add info
Add round
07 Sep 2017
WuXi NextCODE
WuXi NextCODE
$240,000,000
Venture capital (Series B)
Temasek Holdings, Sequoia China, Amgen Ventures, +2

WuXi NextCODE racks up $240 mln Series B

PE Hub
+1
23 Aug 2017
GNS Healthcare
GNS Healthcare
$6,000,000
Venture capital (Series C)
Amgen Ventures

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

Xconomy
+1
25 Apr 2017
Science 37
Science 37
$29,000,000
Venture capital (Series C)
Redmile Group, Lux Capital, Glynn Capital Management, +3

GV joins $29 million investment into Science 37 to bring clinical trials to the home

VentureBeat
+1
20 Jul 2016
Akili Interactive
Akili Interactive
$11,900,000
Venture capital (Series B)
Amgen Ventures, Merck Ventures

Amgen and Merck KGaA Invest in Bostons Akili Increasing Funding Round to 42 4 Million

biospace
+1
08 Mar 2016
Tizona Therapeutics
Tizona Therapeutics
$43,000,000
Venture capital (Series B)
Canaan Partners, InterWest Partners, MPM Capital, +4

Tizona Therapeutics Closes $43M Series B Funding

FinSMEs
07 Jan 2016
Alector
Alector
$29,500,000
Venture capital (Series D)
Polaris Partners, OrbiMed, Topspin Partners, +6

Alector Raises $29.5M in Series D Financing

FinSMEs
18 Feb 2015
miRagen Therapeutics
miRagen Therapeutics
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
10 Jan 2014
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc.
$13,500,000
Venture capital (Series B)
DAG Ventures, Kleiner Perkins Caufield & Byers, Celgene, +4

Atara Biotherapeutics Holds $13.5M Second Close of Series B Financing

FinSMEs
17 Dec 2013
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc.
$38,500,000
Venture capital (Series B)
DAG Ventures, Kleiner Perkins Caufield & Byers, Celgene, +3

Atara Biotherapeutics Secures $38.5M in Series B Financing

FinSMEs
14 Jul 2005
Integrated Diagnostics
Integrated Diagnostics
Venture capital (Series A)
ARCH Venture Partners, MPM Capital, OVP Venture Partners, +3

PE Week Wire - Friday, July 15

PE Hub